[RNA polymerase mutants of bacteria].
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects / Q000201:enzymology*; D001431:Bacteriological Techniques; D003470:Culture Media; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000201:enzymology / Q000302:isolation & purification; D005947:Glucose / Q000494:pharmacology; D009154:Mutation; D012316:RNA Nucleotidyltransferases / Q000378:metabolism*; D012329:RNA, Bacterial / Q000096:biosynthesis; D012293:Rifampin / Q000494:pharmacology; D013310:Streptovaricin / Q000494:pharmacology; D013696:Temperature
D000900:Anti-Bacterial Agents; D003470:Culture Media; D012329:RNA, Bacterial; D013310:Streptovaricin; D012316:RNA Nucleotidyltransferases; D005947:Glucose; D012293:Rifampin